We have previously demonstrated that silencing of uL3 in colon and lung cancer cells is associated to chemoresistance and that the ectopic expression of uL3 re-sensitive these cells to chemotherapeutic treatment [9,17]. The gene discussed is RPL3; the disease is lung carcinoma.